Business Today: Latest Business News, India economy News, Stock Markets, Sensex, Mutual Funds and Indian Tax

Total 44 results found. Search for [ Syngene ]

Results 1 to 21 of 44
June 14, 2019
Equity benchmark indices extended losses in the last hour of the trade to end in the red, after sources said that India will impose retaliatory tariffs on 29 US products.Sensex ended down by 289.29 points at 38,452, while Nifty fell by 90.75 points to close at 11,823. Overall 26 out of the 30 stocks ended in the red on Sensex and 42 out of the 50 stocks were negative on Nifty.On the sectoral front, all indices closed in the red. Media and Realty were the biggest losers and wer...

January 22, 2019

E Kumar Sharma
New Delhi, April 27, 2018
While Biocon's Q4 results show margins below expectations, the market is more focused on the company's progress on the biosimilar front.

March 26, 2018

February 23, 2018

January 5, 2018

New Delhi, April 27, 2016
Biotechnology major Biocon today reported 79 per cent jump in consolidated net profit at Rs 360.9 crore for the fourth quarter ended March 31, 2016, on the back of exceptional income and robust sales.

New Delhi, January 22, 2016
Standalone total income from operations of the company also rose to Rs 280.4 crore for the quarter under consideration as against Rs 227.6 crore for the same period year ago.

E Kumar Sharma
January 5, 2016
The appointment of Jonathan Hunt was a transition waiting to happen as Peter Bains, the current CEO is to retire in March 2016.

Niti Kiran
New Delhi, December 30, 2015
Year 2015 saw Rs 68,608 crore being raised through public equity markets, a 76 per cent rise over the  Rs 39,067 crore of 2014, according to data released by PRIME Database.

Sheena Sanam
December 24, 2015
While IPOs worth Rs 14,000 crore are already in the final stages of hitting the market, experts say the overall pipeline currently stands at well in excess of Rs 50,000 crore.

Mumbai, December 23, 2015
On BSE, Dr Lal's stock opened at Rs 717, up 30.36 per cent as against the issue price. It touched a high of Rs 842.40 and a low of Rs 715.50 and settled the day 14.94 per cent higher to Rs 824.15.

Mumbai, December 23, 2015
The stock listed at Rs 1,380, a sharp gain of 31.42 per cent over the issue price, on BSE. It touched a high of Rs 1,401.40 and a low of Rs 1,355.40 in the early trade.

Mumbai, December 11, 2015
The IPO of Dr Lal generated demand worth Rs 21,000 crore, as it received bids for 27,04,74,780 shares as against the total issue size of 81,20,000 shares.

Mumbai, November 26, 2015
As many as 11 companies out of the total 18 that got listed this year are trading above their issue price, an analysis of the performance of the newly-listed firms showed.

BT Online
New Delhi, November 16, 2015
The stock ended the day 15.16 per cent up after hitting an intraday high of Rs 222.70, up 23.72 per cent against the issue price.

New Delhi, October 26, 2015
In case of Coffee Day, even the portions reserved for HNIs, as also their own employees, remain under-subscribed, although both the IPOs managed to sail through.

New Delhi, October 21, 2015
The consolidated revenue of Biocon was up by 11.38 per cent at Rs 861 crore during the quarter compared to Rs 773 crore in the year-ago period.

Team BT
September 5, 2015
A brief look at the women in BT's top league.

E. Kumar Sharma
August 13, 2015
In an interview with E. Kumar Sharma, Ramanan Laxminarayan, Vice President for Research and Policy at the Public Health Foundation of India, discusses the antibiotics scenario and challenges.

PAGES 1 OF 3  123